pcn poster

Posters

EnBrace HR for Depression Treatment and Prevention in Women Trying to Conceive and Early Pregnancy

Background: Women who are pregnant or are planning pregnancy often seek alternatives to standard antidepressants (ADs) for the treatment of major depressive disorder (MDD). The objectiv...

Lee S. Cohen , DPM, FACFAS;

Marlene Freeman , MD;

Gina Savella , BS;

Taylor Church , BS;

Lina Gόez-Mogollόn , MD, MSc;

Alexandra Sosinsky , BS;

Olivia Noe , BS;

Anjali J Kaimal ;

03/01/2019

Efficacy of Lurasidone in Child and Adolescent Patients With Bipolar I Depression and Anxiety: A Post-hoc Analysis

Objective: To evaluate the efficacy of lurasidone in treating pediatric patients with bipolar depression who presented with high levels of anxiety.

Antony Loebel , MD;

Robert Goldman , PhD;

Ling Deng , PhD;

Andrei Pikalov , MD, PhD;

Michael Tocco , PhD;

Mark Owens , DO;

03/01/2019

Schizophrenia Now: Are Physicians Up to Speed with Optimal Management and Emerging Treatments?

Background: To assess physicians’ practice patterns in current management and knowledge of emerging treatments for schizophrenia. Methods: • A 27-question online assessment survey wa...

03/01/2019

Sodium Oxybate Treatment of Narcolepsy in Pediatric Patients: Long-term Efficacy and Safety

Objective: To evaluate the long-term efficacy and safety of sodium oxybate (SXB) treatment for narcolepsy in pediatric patients in a placebo-controlled, randomized-withdrawal study with a...

Carol Rosen , MD;

Chad Ruoff , MD;

Diane Guinta , PhD;

Rupa Parvataneni , MS;

Jed Black , MD;

Emmanuel Mignot , MD, PhD;

Y. Grace Wang , MD;

Giuseppe Plazzi , MD;

Yves Dauvilliers , MD, PhD;

Michel Lecendreux , MD;

03/01/2019

Sodium Oxybate Treatment of Narcolepsy in Pediatric Patients: Long-term Efficacy and Safety

Objective: To evaluate the long-term efficacy and safety of sodium oxybate (SXB) treatment for narcolepsy in pediatric patients in a placebo-controlled, randomized-withdrawal study with a...

03/01/2019

Success of CME at Improving Physicians’ Knowledge of LAIs for Bipolar Disorder

Introduction: We sought to determine whether continuing medical education (CME) improves knowledge regarding bipolar disorder (BPD) and its treatment with the use of long acting injectabl...

Jovana Lubarda , PhD;

Marcello Morgan , MD, MPH;

Leslie Citrome , MD;

Roger McIntyre , MD, FRCPC;

Piyali Chatterjee-Shin ;

03/01/2019

Symptomatic and Functional Response to Brexpiprazole Treatment in Patients With Acute Schizophrenia by Age

Introduction: The efficacy and safety of brexpiprazole in the treatment of schizophrenia have been demonstrated in short- and long-term studies. This post-hoc analysis assessed the propor...

Catherine Weiss , PhD;

Stine Rasmussen Meehan , PhD;

H. Lundbeck ;

Peter Zhang , PhD;

Erin MacKenzie , PhD;

Francois Therrien , PharmD;

03/01/2019

The Cost of Incident Treatment Resistant Schizophrenia in Commercial Insurance Beneficiaries

Background: Treatment-resistant schizophrenia (TRS) occurs in up to 30% of people with schizophrenia. Previous studies of TRS-associated costs were based upon management methods no longe...

03/01/2019

The Effects of Mindfulness on Depression and Anxiety

Purpose: To evaluate the effectiveness of a mindfulness-based intervention to reduce the symptoms of depression and anxiety.Background: Evidence suggests that the combination of mindfuln...

03/01/2019

The Frameworks to Support Adherence in Mental Health Working Group: Translating Science Into Action to Improve Patient Care

Shared decision making (SDM) involves healthcare providers and patients collaborating to make optimal healthcare decisions that align with patients’ goals and values. Patient decision aid...

Heidi Waters , PhD, MBA;

Dawn Velligan , PhD;

Felicia Forma , BSc;

Susan Bergeson ;

Martha Sajatovic , MD;

Jason Caplan , MD;

Michael Measom , MD;

Monica Oss , MS;

Michael Townsend , MA;

03/01/2019

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Rapid Refresh

Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics

04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...

Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...

Andrew Penn, MS, PMHNP, and...

04/11/2024

Psych Congress NP Institute

Rapid Refresh

Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder

04/10/2024

Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...

Amber Hoberg, PMHNP-BC,...

04/10/2024

Psych Congress NP Institute

Clinical Pearls

Tolerability Testing in Long-Acting Injectable Prescriptions

04/03/2024

Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.

Posters

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Sign Up

Specialties

Events

Year Round Education

HMP Global Products